back to square one all
original t/o price was $2
this now has to be upgraded to the 4-5 range as so much more has happened since 2017
SP. prior will rise on 1/ fda - sub $1 but high and close
approval for Sleep apnea (spelt wrong) ) will plus20v
commercial agreements will put 20c ,50c, $1
these numbers look like getting to a $3 plus space
still believe BOD target is around $4 -$5
timeframe - within 1 year but realistically sooner
- Forums
- ASX - By Stock
- RAP
- A new Beginning...
A new Beginning..., page-3019
-
-
- There are more pages in this discussion • 430 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RAP (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online